Jacob Scheinerman

Papers

Total Citations

H-Index

About

Dr. Jacob Scheinerman is a pioneering cardiothoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung cancer treatment, particularly non-small-cell lung cancer (NSCLC). His major contributions center on optimizing surgical outcomes by comparing video-assisted thoracoscopic surgery (VATS) and robotic platforms. In his highly cited 2020 study, "Switching from Thoracoscopic to Robotic Platform for Lobectomy: Report of Learning Curve and Outcome," Dr. Scheinerman meticulously analyzed the learning curve and clinical outcomes for experienced VATS surgeons transitioning to robotic lobectomy. This work addressed critical barriers to robotic adoption—including increased costs and technical challenges—providing evidence that experienced surgeons can successfully adapt with acceptable outcomes. With 11 citations, this study has informed surgical decision-making and training protocols worldwide. Dr. Scheinerman’s research bridges the gap between innovation and practical implementation, helping shape best practices in thoracic oncology. His work underscores a commitment to improving patient care through rigorous evaluation of emerging technologies, making him a key voice in the evolution of minimally invasive thoracic surgery.